1. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. 2019; OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 27:1578–89. DOI:
10.1016/j.joca.2019.06.011. PMID:
31278997.
Article
2. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2020; 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 72:220–33. Erratum in: Arthritis Rheumatol 2021;73:799. DOI:
10.1002/art.41142. PMID:
31908163. PMCID:
PMC10518852.
Article
3. Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, et al. 2019; 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 78:16–24. DOI:
10.1136/annrheumdis-2018-213826. PMID:
30154087.
Article
4. Choi JH, Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, et al. 2002; Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage. 10:471–8. DOI:
10.1053/joca.2002.0526. PMID:
12056850.
Article
5. Lung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, et al. 2004; A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: a herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. Am J Chin Med. 32:291–301. DOI:
10.1142/S0192415X04001941. PMID:
15315266.
Article
6. Hartog A, Hougee S, Faber J, Sanders A, Zuurman C, Smit HF, et al. 2008; The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators. Phytomedicine. 15:313–20. DOI:
10.1016/j.phymed.2007.09.005. PMID:
17949960.
Article
7. Choi CH, Kim TH, Sung YK, Choi CB, Na YI, Yoo H, et al. 2014; SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes. Korean J Intern Med. 29:647–55. DOI:
10.3904/kjim.2014.29.5.647. PMID:
25228841. PMCID:
PMC4164729.
Article
8. Woo Y, Hyun MK. 2017; Evaluation of cardiovascular risk associated with SKI306X use in patients with osteoarthritis and rheumatoid arthritis. J Ethnopharmacol. 207:42–6. DOI:
10.1016/j.jep.2017.06.003. PMID:
28602866.
Article
9. Kim HR, Kim KW, Kim BM, Won JY, Min HK, Lee KA, et al. 2019; Regulation of Th17 cytokine-induced osteoclastogenesis via SKI306X in rheumatoid arthritis. J Clin Med. 8:1012. DOI:
10.3390/jcm8071012. PMID:
31295961. PMCID:
PMC6678573.
Article
10. Choi J, Kim SH, Kim S. 2012; Suppressive effects of PG201, an antiarthritic botanical formulation, on lipopolysaccharide-induced inflammatory mediators in Raw264.7 cells. Exp Biol Med (Maywood). 237:499–508. DOI:
10.1258/ebm.2011.011203. PMID:
22442340.
Article
11. Shin SS, Jin M, Jung HJ, Kim B, Jeon H, Choi JJ, et al. 2003; Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice. Rheumatology (Oxford). 42:665–72. DOI:
10.1093/rheumatology/keg209. PMID:
12709543.
Article
12. Park KC, Park EJ, Kim ER, Kim Y, Chung SH, Cho BW, et al. 2005; Therapeutic effects of PG201, an ethanol extract from herbs, through cartilage protection on collagenase-induced arthritis in rabbits. Biochem Biophys Res Commun. 331:1469–77. DOI:
10.1016/j.bbrc.2005.04.030. PMID:
15883039.
Article
13. Yoo WH, Yoo HG, Park SH, Baek HJ, Lee YJ, Shim SC, et al. 2014; Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study. Rheumatol Int. 34:1369–78. DOI:
10.1007/s00296-014-2964-8. PMID:
24531687.
Article
14. Ha CW, Park YB, Min BW, Han SB, Lee JH, Won YY, et al. 2016; Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis. J Ethnopharmacol. 181:1–7. DOI:
10.1016/j.jep.2016.01.029. PMID:
26821189.
Article
15. Choi J, Lee J, Lee J, Kim SH, Kim J, Kim S. 2013; PG201 downregulates the production of nitrite by upregulating heme oxygenase-1 expression through the control of phosphatidylinositol 3-kinase and NF-E2-related factor 2. Nitric Oxide. 33:42–55. DOI:
10.1016/j.niox.2013.05.003. PMID:
23747519.
Article
16. Kim HJ, Kim HM, Ryu B, Lee WS, Shin JS, Lee KT, et al. 2016; Constituents of PG201 (Layla(®)), a multi-component phytopharmaceutical, with inhibitory activity on LPS-induced nitric oxide and prostaglandin E2 productions in macrophages. Arch Pharm Res. 39:231–9. DOI:
10.1007/s12272-015-0654-z. PMID:
26306655.
Article
17. Bae MJ, Choi J, Kim HK, Lim S, Kim S. 2018; PG201 protects mice from experimental autoimmune encephalomyelitis via suppression of effector T cell activation. Phytomedicine. 43:150–7. DOI:
10.1016/j.phymed.2018.04.026. PMID:
29747748.
Article
18. Kim JK, Park SW, Kang JW, Kim YJ, Lee SY, Shin J, et al. 2012; Effect of GCSB-5, a herbal formulation, on monosodium iodoacetate-induced osteoarthritis in rats. Evid Based Complement Alternat Med. 2012:730907. DOI:
10.1155/2012/730907. PMID:
22474519. PMCID:
PMC3303749.
Article
19. Wang CC, Chen LG, Yang LL. 1999; Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk. Cancer Lett. 145:151–7. DOI:
10.1016/S0304-3835(99)00248-7. PMID:
10530783.
Article
20. Makarov SS. 2001; NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 3:200–6. DOI:
10.1186/ar300. PMID:
11438035. PMCID:
PMC128895.
21. Zhu J, Gao X, Xie WL, Jin YZ, Sun WJ. 2005; [Effect of geniposide on serum IL-1beta and TNF-alpha of rheumatoid arthritis rats]. Zhongguo Zhong Yao Za Zhi. 30:708–11. Chinese.
22. Kim BH, Park KS, Chang IM. 2009; Elucidation of anti-inflammatory potencies of Eucommia ulmoides bark and Plantago asiatica seeds. J Med Food. 12:764–9. DOI:
10.1089/jmf.2008.1239. PMID:
19735174.
23. Chung HJ, Lee HS, Shin JS, Lee SH, Park BM, Youn YS, et al. 2010; Modulation of acute and chronic inflammatory processes by a traditional medicine preparation GCSB-5 both in vitro and in vivo animal models. J Ethnopharmacol. 130:450–9. DOI:
10.1016/j.jep.2010.05.020. PMID:
20621661.
Article
24. Lee CH, Kim SH, Lee JS, Cho KH, Kim JS, Cho SH, et al. 2005; Evaluation of the antinociceptive properties of GCSB-5, a herbal formulation. Korean J Pharmacogn. 36:299–304.
25. Park YG, Ha CW, Han CD, Bin SI, Kim HC, Jung YB, et al. 2013; A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. J Ethnopharmacol. 149:816–24. DOI:
10.1016/j.jep.2013.08.008. PMID:
23954277.
Article
26. Ha CW, Park YB, Kyung HS, Han CS, Bae KC, Lim HC, et al. 2016; Gastrointestinal safety and efficacy of long-term GCSB-5 use in patients with osteoarthritis: a 24-week, multicenter study. J Ethnopharmacol. 189:310–8. DOI:
10.1016/j.jep.2016.05.031. PMID:
27196293.
Article
27. Park JK, Shin K, Kang EH, Ha YJ, Lee YJ, Lee KH, et al. 2016; Efficacy and tolerability of GCSB-5 for hand osteoarthritis: a randomized, controlled trial. Clin Ther. 38:1858–68.e2. DOI:
10.1016/j.clinthera.2016.06.016. PMID:
27449412.
Article
28. Cho HK, Kim SY, Choi MJ, Baek SO, Kwak SG, Ahn SH. 2016; The effect of GCSB-5 a new herbal medicine on changes in pain behavior and neuroglial activation in a rat model of lumbar disc herniation. J Korean Neurosurg Soc. 59:98–105. DOI:
10.3340/jkns.2016.59.2.98. PMID:
26962414. PMCID:
PMC4783491.
Article
30. Bang J, Kim G, Park SY, Jung HR, Kim SH, Kim JM. 2023; GCSB-5 regulates inflammatory arthritis and pain by modulating the mitogen-activated protein kinase signaling pathway in a murine model of rheumatoid arthritis. Arch Rheumatol. 38:566–78. DOI:
10.46497/ArchRheumatol.2023.9643. PMID:
38125068. PMCID:
PMC10728744.
Article
31. Lippiello L, Nardo JV, Harlan R, Chiou T. 2008; Metabolic effects of avocado/soy unsaponifiables on articular chondrocytes. Evid Based Complement Alternat Med. 5:191–7. DOI:
10.1093/ecam/nem132. PMID:
18604259. PMCID:
PMC2396479.
Article
32. Henrotin YE, Labasse AH, Jaspar JM, De Groote DD, Zheng SX, Guillou GB, et al. 1998; Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol. 17:31–9. DOI:
10.1007/BF01450955. PMID:
9586676.
Article
33. Kharazmi A. 2008; Laboratory and preclinical studies on the anti-inflammatory and anti-oxidant properties of rosehip powder - identification and characterization of the active component GOPO®. Osteoarthritis Cartilage. 16(Suppl 1):S5–7. DOI:
10.1016/S1063-4584(08)60003-5.
Article
34. Simental-Mendía M, Sánchez-García A, Acosta-Olivo CA, Vilchez-Cavazos F, Osuna-Garate J, Peña-Martínez VM, et al. 2019; Efficacy and safety of avocado-soybean unsaponifiables for the treatment of hip and knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials. Int J Rheum Dis. 22:1607–15. DOI:
10.1111/1756-185X.13658. PMID:
31328413.
Article
35. Basch E, Boon H, Davies-Heerema T, Foppo I, Hashmi S, Hasskarl J, et al. 2004; Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 4:63–83. DOI:
10.1080/J157v04n03_06.
36. Badria FA, El-Farahaty T, Shabana AA, Hawas SA, El-Batoty MF. 2002; Boswellia-curcumin preparation for treating knee osteoarthritis: a clinical evaluation. Altern Complement Ther. 8:341–8. DOI:
10.1089/107628002761574635.
Article
38. Sengupta K, Golakoti T, Marasetti AK, Tummala T, Ravada SR, Krishnaraju AV, et al. 2009; Inhibition of TNFα production and blocking of mitogen-activated protein kinase/NFκB activation in lipopolysaccharide-induced THP-1 human monocytes by 3-O-acetyl-11-keto-β-boswellic acid. J Food Lipids. 16:325–44. DOI:
10.1111/j.1745-4522.2009.01150.x.
Article
39. Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J. 2020; Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 20:225. DOI:
10.1186/s12906-020-02985-6. PMID:
32680575. PMCID:
PMC7368679.
Article
40. Jhun J, Na HS, Cho KH, Kim J, Moon YM, Lee SY, et al. 2021; A green-lipped mussel reduces pain behavior and chondrocyte inflammation and attenuated experimental osteoarthritis progression. PLoS One. 16:e0259130. DOI:
10.1371/journal.pone.0259130. PMID:
34855756. PMCID:
PMC8638931.
Article
41. Siriarchavatana P, Kruger MC, Miller MR, Tian HS, Wolber FM. 2019; The preventive effects of Greenshell mussel (
Perna canaliculus) on early-stage metabolic osteoarthritis in rats with diet-induced obesity. Nutrients. 11:1601. DOI:
10.3390/nu11071601. PMID:
31311115. PMCID:
PMC6683089.
Article
42. Abshirini M, Coad J, Wolber FM, von Hurst P, Miller MR, Tian HS, et al. 2021; Green-lipped (greenshell™) mussel (Perna canaliculus) extract supplementation in treatment of osteoarthritis: a systematic review. Inflammopharmacology. 29:925–38. DOI:
10.1007/s10787-021-00801-2. PMID:
33738701. PMCID:
PMC8298224.
Article
43. Abshirini M, Coad J, Wolber FM, von Hurst P, Miller MR, Tian HS, et al. 2022; Effects of Greenshell™ mussel intervention on biomarkers of cartilage metabolism, inflammatory markers and joint symptoms in overweight/obese postmenopausal women: a randomized, double-blind, and placebo-controlled trial. Front Med (Lausanne). 9:1063336. DOI:
10.3389/fmed.2022.1063336. PMID:
36544504. PMCID:
PMC9760926.
Article
44. Stebbings S, Gray A, Schneiders AG, Sansom A. 2017; A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee. BMC Complement Altern Med. 17:416. DOI:
10.1186/s12906-017-1907-9. PMID:
28830491. PMCID:
PMC5568208.
Article
45. Winther K, Apel K, Thamsborg G. 2005; A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo controlled clinical trial. Scand J Rheumatol. 34:302–8. DOI:
10.1080/03009740510018624. PMID:
16195164.
46. Warholm O, Skaar S, Hedman E, Mølmen HM, Eik L. 2003; The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial. Curr Ther Res Clin Exp. 64:21–31. DOI:
10.1016/S0011-393X(03)00004-3. PMID:
24944354.
Article
47. Schwager J, Richard N, Schoop R, Wolfram S. 2014; A novel rose hip preparation with enhanced anti-inflammatory and chondroprotective effects. Mediators Inflamm. 2014:105710. DOI:
10.1155/2014/105710. PMID:
25371599. PMCID:
PMC4211164.
Article
48. Kocaadam B, Şanlier N. 2017; Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 57:2889–95. DOI:
10.1080/10408398.2015.1077195. PMID:
26528921.
49. Soleimani V, Sahebkar A, Hosseinzadeh H. 2018; Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytother Res. 32:985–95. DOI:
10.1002/ptr.6054. PMID:
29480523.
50. Liczbiński P, Michałowicz J, Bukowska B. 2020; Molecular mechanism of curcumin action in signaling pathways: review of the latest research. Phytother Res. 34:1992–2005. DOI:
10.1002/ptr.6663. PMID:
32141677.
Article
51. Zeng L, Yu G, Hao W, Yang K, Chen H. 2021; The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep. 41:BSR20210817. DOI:
10.1042/BSR20210817. PMID:
34017975. PMCID:
PMC8202067.
Article
52. Lau KM, Yue GG, Chan YY, Kwok HF, Gao S, Wong CW, et al. 2019; A review on the immunomodulatory activity of
Acanthopanax senticosus and its active components. Chin Med. 14:25. DOI:
10.1186/s13020-019-0250-0. PMID:
31388349. PMCID:
PMC6670126.
53. Yoon TJ, Yoo YC, Lee SW, Shin KS, Choi WH, Hwang SH, et al. 2004; Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol. 93:247–53. DOI:
10.1016/j.jep.2004.03.052. PMID:
15234760.
Article
54. Lin J, Li X, Qi W, Yan Y, Chen K, Xue X, et al. 2018; Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes. Int Immunopharmacol. 64:238–45. DOI:
10.1016/j.intimp.2018.09.003. PMID:
30205322.
Article
55. He X, Wang X, Fang J, Chang Y, Ning N, Guo H, et al. 2017; The genus Achyranthes: a review on traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol. 203:260–78. DOI:
10.1016/j.jep.2017.03.035. PMID:
28347832.
56. Kim D, Lee D, Oh D, Jeong HC, Lee SJ, Sohn J, et al. 2020; A mixture containing fermented
Achyranthes japonica Nakai ameliorates osteoarthritis in knee joints of monoiodoacetate-injected rats. J Med Food. 23:811–7. DOI:
10.1089/jmf.2019.4552. PMID:
32614635.
57. Kang HS, Lee HS, Yu HJ, Jang SH, Seo Y, Cho HY, et al. 2017; Effect of fermented Achyranthes japonica (Miq.) Nakai extract on osteoarthritis. Korean J Food Sci Technol. 49:104–9. DOI:
10.9721/KJFST.2017.49.1.104.
Article
58. Chen Z, Wu G, Zheng R. 2020; A systematic pharmacology and in vitro study to identify the role of the active compounds of Achyranthes bidentata in the treatment of osteoarthritis. Med Sci Monit. 26:e925545. DOI:
10.12659/MSM.925545.
Article
59. Hong JM, Shin JK, Kim JY, Jang MJ, Park SK, Lee JH, et al. 2018; BST106 protects against cartilage damage by inhibition of apoptosis and enhancement of autophagy in osteoarthritic rats. Biol Pharm Bull. 41:1257–68. DOI:
10.1248/bpb.b18-00207. PMID:
29794403.
Article
60. Lee JH, Seo JY, Ko NY, Chang SH, Her E, Park T, et al. 2004; Inhibitory activity of Chrysanthemi sibirici herba extract on RBL-2H3 mast cells and compound 48/80-induced anaphylaxis. J Ethnopharmacol. 95:425–30. DOI:
10.1016/j.jep.2004.08.023. PMID:
15507370.
Article
61. Byun JH, Choi CW, Jang MJ, Lim SH, Han HJ, Choung SY. 2020; Anti-osteoarthritic mechanisms of
Chrysanthemum zawadskii var. latilobum in MIA-induced osteoarthritic rats and interleukin-1β-induced SW1353 human chondrocytes. Medicina (Kaunas). 56:685. DOI:
10.3390/medicina56120685. PMID:
33321982. PMCID:
PMC7762971.
Article
62. Ha JK, Kim JS, Kim JY, Yun JB, Kim YY, Chung KS. 2021; Efficacy of GCWB106 (Chrysanthemum zawadskii var. latilobum extract) in osteoarthritis of the knee: a 12-week randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 100:e26542. DOI:
10.1097/MD.0000000000026542. PMID:
34190191. PMCID:
PMC8257904.
63. Koo HJ, Yoon WJ, Sohn EH, Ham YM, Jang SA, Kwon JE, et al. 2014; The analgesic and anti-inflammatory effects of Litsea japonica fruit are mediated via suppression of NF-κB and JNK/p38 MAPK activation. Int Immunopharmacol. 22:84–97. DOI:
10.1016/j.intimp.2014.06.007. PMID:
24968348.
Article
64. Jeong YJ, Kim I, Cho JH, Park DW, Kwon JE, Jung MW, et al. 2015; Anti-osteoarthritic effects of the Litsea japonica fruit in a rat model of osteoarthritis induced by monosodium iodoacetate. PLoS One. 10:e0134856. DOI:
10.1371/journal.pone.0134856. PMID:
26244981. PMCID:
PMC4526681.
Article
65. Ahn Y, Kwon O, Kim EA, Yoon WJ, Kim JH, Kim JY. 2017; Randomized double-blind placebo-controlled study of the efficacy of
Litsea japonica fruit extract in subjects with mild to moderate knee osteoarthritis. J Funct Foods. 34:304–10. DOI:
10.1016/j.jff.2017.05.005.
67. Cheng W, Jing J, Wang Z, Wu D, Huang Y. 2017; Chondroprotective effects of ginsenoside Rg1 in human osteoarthritis chondrocytes and a rat model of anterior cruciate ligament transection. Nutrients. 9:263. DOI:
10.3390/nu9030263. PMID:
28287423. PMCID:
PMC5372926.
Article
68. Cheng W, Wu D, Zuo Q, Wang Z, Fan W. 2013; Ginsenoside Rb1 prevents interleukin-1 beta induced inflammation and apoptosis in human articular chondrocytes. Int Orthop. 37:2065–70. DOI:
10.1007/s00264-013-1990-6. PMID:
23835558. PMCID:
PMC3779573.
Article
69. Chen M, Zhou S, Liu L, Wen Y, Chen L. 2021; Notoginsenoside R1 alleviates the inflammation of osteoarthritis by activating the Nrf2/HO-1 signalling pathway in vitro and in vivo. J Funct Foods. 85:104666. DOI:
10.1016/j.jff.2021.104666.
Article
70. Kim HI, Chon SJ, Seon KE, Seo SK, Choi YR. 2021; Clinical effects of Korean red ginseng in postmenopausal women with hand osteoarthritis: a double-blind, randomized controlled trial. Front Pharmacol. 12:745568. DOI:
10.3389/fphar.2021.745568. PMID:
34858175. PMCID:
PMC8630590.
Article